AU Patent

AU4010395A — Compositions for increased bioavailability of orally delivered therapeutic agents

Assigned to Amgen Inc · Expires 1996-05-23 · 30y expired

What this patent protects

Patent listed against Remodulin.

Drugs covered by this patent

Patent Metadata

Patent number
AU4010395A
Jurisdiction
AU
Classification
—
Expires
1996-05-23
Drug substance claim
No
Drug product claim
No
Assignee
Amgen Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.